about
T cell epitopes and post-translationally modified epitopes in type 1 diabetesBeyond model antigens: high-dimensional methods for the analysis of antigen-specific T cellsImmunotherapy in autoimmune type 1 diabetesStructure of a Domain-Swapped FOXP3 Dimer on DNA and Its Function in Regulatory T CellsStructural Basis of Chronic Beryllium Disease: Linking Allergic Hypersensitivity and AutoimmunityMolecular Interactions Governing Autoantigen Presentation in Type 1 DiabetesImmunogenetics of type 1 diabetes mellitusEnvironmental risk factors for type 1 diabetesT cells and their eons-old obsession with MHCVasostatin-1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD miceHands-on workshops as an effective means of learning advanced technologies including genomics, proteomics and bioinformaticsExtrathymic Aire-expressing cells are a distinct bone marrow-derived population that induce functional inactivation of CD4⁺ T cellsGenetic and epigenetic variation in the lineage specification of regulatory T cells.Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft tolerance.Navigating diabetes-related immune epitope data: resources and tools provided by the Immune Epitope Database (IEDB)Biological function and clinical relevance of chromogranin A and derived peptides.Insulin as a key autoantigen in the development of type 1 diabetesPluripotent Nontumorigenic Adipose Tissue-Derived Muse Cells have Immunomodulatory Capacity Mediated by Transforming Growth Factor-β1.Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.B cells and type 1 diabetes ...in mice and men.Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register.Extra-thymically induced regulatory T cells: do they have potential in disease prevention?IRAK-M deficiency promotes the development of type 1 diabetes in NOD mice.The central role of antigen presentation in islets of Langerhans in autoimmune diabetesStructure-based selection of small molecules to alter allele-specific MHC class II antigen presentationDendritic cell-targeted pancreatic beta-cell antigen leads to conversion of self-reactive CD4(+) T cells into regulatory T cells and promotes immunotolerance in NOD mice.On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets.Treg vaccination with a strong-agonistic insulin mimetope.Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364-384))Anti-atherogenic peptide Ep1.B derived from apolipoprotein E induces tolerogenic plasmacytoid dendritic cells.Detection of T cell responses to a ubiquitous cellular protein in autoimmune diseaseA minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg 17) cells in type 1 diabetes in non-obese diabetic mice.An update on the use of NOD mice to study autoimmune (Type 1) diabetes.The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD miceThe B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetesT cell receptor recognition of self and foreign antigens in the induction of autoimmunity.Treg vaccination in autoimmune type 1 diabetes.
P2860
Q26787014-D3F39F48-CE15-471B-ABB6-0666037333BDQ27013972-42F85D55-50B7-498A-8D96-D62554A2C1BCQ27025619-AF36F3DF-575E-4381-A8B0-B6B606584C4CQ27667400-EB24A199-A7EE-4B90-9379-2D5492E2E18BQ27684560-E0202C55-620E-44F3-B852-37064ECDCD3EQ28084487-6BA4D916-D55A-42DE-9884-2473C0AFC426Q28087365-4220BA0A-E8C6-492A-B93C-69BC21694638Q28276366-B257B9EC-D59B-4D3E-88BB-D42654E46191Q28276597-C8560588-ECC5-4391-B231-249FADE9B2F2Q28306169-ABB8B81C-3B24-4328-917F-0AAF838A2DAFQ28387396-1A1EEA5C-CB34-478E-8B5D-8E43069F7F8CQ28593219-8F0A6648-B76C-4944-9E18-504627CEBF3DQ30278461-957A2580-DA53-4C1B-826E-5AAB0818C513Q30573918-682F92F9-E2E9-40EF-9FE9-5B6017DCC11CQ30843737-8E4FC526-F823-4E77-8D39-6247800C0C56Q33574106-6FB29954-D7EA-4881-88C4-4D935534F554Q33712227-F0AC893E-09E6-4C0D-8C85-D146C004246AQ33722118-A62E9735-B33A-4536-99F6-774029ABEB99Q33750667-1EB663C3-1763-4BE9-931A-CAF2E97DDF57Q33926306-58FCCDEC-F50B-43BE-A8B5-80206522FB5FQ33934705-6749DBFE-5606-4763-B73D-00E1541F69D9Q33949282-FA399CE6-F370-4ADB-B37B-B88A5F19E0AAQ33959795-5A6F50D2-7A0E-4CA1-9BD4-C002D851871BQ33986306-18157C00-A583-44A3-AC62-F05442DA4F9BQ34063488-ECC98D1B-BF33-4698-B519-F286951EF081Q34072331-2D036704-C191-478A-9B9D-D170AA2322ADQ34150236-734C5B8C-3480-4B0E-A52B-D4437EFC8CB8Q34309199-33575ECE-0087-4FDC-AA64-3833B8BEDBD4Q34327132-BE6C1BA6-E436-4027-98DF-C596A7B19154Q34375578-157968AA-8208-40AA-BC07-52CFD7DDACA2Q34376655-4F44E945-F5F2-4A3B-B5D8-1DB4A19609AFQ34418181-A44CC6C0-6FB9-4ED8-BCDE-3A4D1A7525FDQ34443963-92E18EF8-D623-4E19-ACF7-172245204FB6Q34452991-0B0302D7-29F1-4220-9DE8-31910C9FF90CQ34488588-96B1F224-A9CD-4617-B2FF-3064C01698FFQ34508281-B788AA63-F740-468D-A138-5EDEEB86C736Q34590244-34E8A81C-8E3C-4078-8757-FF7F70528FDBQ34647086-3355AEDD-B174-4158-B7DC-8AFEE0FD15A2Q34777861-4F5D4FE9-FB5F-4DD3-B556-0F1F00B99785Q34957397-6FAF9EC3-89B3-446E-A4E4-E6D8D64A40D3
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Chromogranin A is an autoantigen in type 1 diabetes
@ast
Chromogranin A is an autoantigen in type 1 diabetes
@en
Chromogranin A is an autoantigen in type 1 diabetes
@nl
type
label
Chromogranin A is an autoantigen in type 1 diabetes
@ast
Chromogranin A is an autoantigen in type 1 diabetes
@en
Chromogranin A is an autoantigen in type 1 diabetes
@nl
prefLabel
Chromogranin A is an autoantigen in type 1 diabetes
@ast
Chromogranin A is an autoantigen in type 1 diabetes
@en
Chromogranin A is an autoantigen in type 1 diabetes
@nl
P2093
P2860
P356
P1433
P1476
Chromogranin A is an autoantigen in type 1 diabetes
@en
P2093
Brenda Bradley
Brian D Stadinski
Frances Crawford
Gene Barbour
Jon D Piganelli
Kathryn Haskins
Michael Armstrong
Nichole Reisdorph
Richard Reisdorph
Roger L Powell
P2860
P304
P356
10.1038/NI.1844
P407
P577
2010-03-01T00:00:00Z